PetVivo Holdings Inc a veterinary biotech and biomedical device company engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals Its lead product is Kush a veterinarianadministered joint injection for the treatment of osteoarthritis and lameness in dogs and horses The companys pipeline products include 17 therapeutic devices for veterinary and human clinical applications PetVivo Holdings Inc is headquartered in Minneapolis Minnesota
Financial Ratios (TTM)
Gross Margin
66.05%
Operating Margin
-735.94%
Net Margin
-893.26%
ROA
-226.91%
Price to Book
8.47
Price to Sales
20.73
We value your privacy
We use cookies to analyze traffic and show ads. Accept all cookies, or continue with only the essential ones. Learn more